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Introduction
Central nervous system complications have been reported in up to 25% of patients with Sjögren's syndrome (SjS) [1] ; meningitis is common in SjS patients [2] . There have been previous reports of SjS patients showing meningoencephalitis without characteristic symptoms of xerosis [6] . As meningoencephalitis in primary SjS is treatable, understanding of its clinical features is important in the differential diagnosis of meningoencephalitis. There have been no previous reports of detailed magnetic resonance imaging (MRI) findings of such cases. Here, we report a case of primary SjS presenting with aseptic meningoencephalitis showing reversible cortical lesions on MRI.
Case report
The patient was a 50-year-old Japanese woman. She had no history of cardiovascular risk factors such as hypertension, diabetes mellitus, smoking, hyperlipidemia, heavy drinking, or drug use. Her family history was not contributory. Two weeks before admission to our hospital, she complained of forgetfulness, which was followed by a low-grade fever. When she visited a local hospital, clinical examinations and brain computed tomography (CT) revealed no abnormalities. On the day before admission, she developed psychosis. After establishment of a diagnosis of primary SjS with aseptic meningoencephalitis based on the positive results of serological tests and lip biopsy, the patient was treated with pulsed therapy with intravenous methylprednisolone at 1 g/day for three days four times, followed by oral administration of prednisolone at 60 mg/day with gradual tapering of the dose.
Corticosteroid therapy resulted in marked improvement of both consciousness and CSF findings. The abnormal MRI findings disappeared on day 40 (Fig. 1B) .
The EEG and SPECT findings were normalized within 2 months. She was discharged from our hospital on foot with mild memory disturbance, dysarthria, and ataxic movement two months after admission. There has been no recurrence of meningoencephalitis or other manifestations of SjS during the following four years.
Discussion
We described a patient with primary SjS who initially developed subacute aseptic meningoencephalitis. Although the patient was free of sicca symptoms, the 6 M. Hirohata et al. significant decrease in salivary and lachrymal secretion, inflammatory cell infiltration, and the presence of anti-SS-A and anti-SS-B antibodies satisfied the diagnostic criteria for definite SjS [10] . Subacute progression of memory disturbance and disturbance of consciousness were the initial symptoms of aseptic meningoencephalitis associated with primary SjS in this patient.
Among SjS patients with aseptic meningoencephalitis [2, 3, 4, 5, 6] , there have been a few rare cases in which the patient presented with meningoencephalitis as the initial manifestation [6] ; in such cases, including our patient, memory impairment and disturbance of consciousness are common neuropsychiatry symptoms. The present patient showed characteristic brain MRI findings of well defined multiple focal lesions involving the occipital and limbic cortex, which disappeared after corticosteroid therapy.
In SjS patients with neuropsychiatry manifestations, focal brain lesions on MRI have been reported to be located predominantly within the periventricular or subcortical white matter [7, 9] , except in one case in which the lesions were confined to the limbic cortex [6] . In our patient, the remarkable response of the cortical lesions involving the white matter to steroid therapy indicated inflammatory pathogenesis of the lesions. There have been a few pathological studies of 7 M. Hirohata et al. meningoencephalitis associated with SjS [3, 8] . Necrotizing vasculitis involving numerous small arteries and arterioles was found diffusely in the cerebral cortex of one case at necropsy [8] . Another case showed microinfarcts and focal laminar necrosis, but no evidence of active or healed vasculitis or parenchymal infiltration of inflammatory cells [3] . Although no neuropathological study was performed in our patient, the lack of enhancement by gadolinium-ethylene-diamine-tetraacetic acid (Gd-EDTA) on MRI suggested minimal injury of vascular endothelial cells even if small vessels were involved by meningocortical inflammation.
Finally, we emphasize that evidence of SjS should be investigated in cases of aseptic meningoencephalitis even when sicca symptoms are absent, as in our patient who showed isolated occurrence of meningoencephalitis without other manifestations of SjS for, at least, four years. Furthermore, MRI findings are useful to demonstrate the inflammatory cortical lesions in SjS, which are reversible in response to corticosteroid therapy. 
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